Kerala Ayurveda has informed that the Board Meeting of the Company is scheduled to be held on February 14, 2017, to consider and approve the Unaudited Financial Results for the quarter ended December 31, 2016. Further, in accordance with SEBI (prohibition of insider trading regulations) 2015, the trading window dealing in securities of the company will remain dosed for directors, officers, designated persons of the Company in accordance with the Company’s code of conduct under the above mentioned regulations/ from February 06, 2017 to February 16, 2017.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: